In a groundbreaking move to enhance global healthcare accessibility, Sofia-based company Lab-Away has announced a strategic partnership with the United Nations International Children’s Emergency Fund (UNICEF). Lab-Away, founded in 2021, is renowned for its EU-certified and licensed at-home medical test kits designed for early diagnosis and preventive treatment.
The collaboration with UNICEF aims to address critical public health issues by providing rapid test kits for HIV, Chlamydia, and gonorrhoea to regions with limited access to traditional healthcare services. This partnership reflects Lab-Away’s commitment to social responsibility and its dedication to contributing to international efforts to combat the spread of infectious diseases.
Lab-Away’s at-home medical test kits have gained global recognition for their reliability and adherence to EU certification standards. The company’s innovative approach to healthcare allows individuals to take control of their health by conducting tests in the comfort of their homes, contributing to early diagnosis and preventive treatment.
The CEO of Lab-Away expressed enthusiasm about the collaboration, stating, “Our partnership with UNICEF aligns with our mission to make healthcare accessible to all. By combining our expertise in at-home medical testing with UNICEF’s global reach, we aim to impact communities and contribute to the prevention and early detection of diseases worldwide.”
Lab-Away’s operations span across the globe, reaching diverse communities with their at-home medical test kits. The company’s commitment to quality and innovation is underscored by its EU certification and licensing, ensuring that users receive accurate and reliable results.
